News
Glenmark Pharmaceuticals establishes Glenmark Consumer Care Limited to manufacture and market pharmaceutical and consumer ...
Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.
Investor hopes rose sharply for Merus NV’s phase III trials – data should roll out next year – with bispecific antibody petosemtamab after mid-stage results impressed Wall Street in head and neck ...
Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...
About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...
Global healthcare company Sanofi yesterday formally opened its new flagship US offices at M Station West in Morristown.
Explore more
As has been widely reported on, immunisation rates, including for flu and RSV, have been falling – at a troubling rate – and ...
The U.S. Food and Drug Administration has issued a warning about a rare but severe reaction that can happen to people who ...
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
Sanofi spent $130 million outfitting the 260,000 square feet it now occupies for 2,000 employees at M Station West.
An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer ...
21h
Zacks Investment Research on MSNPharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & MoreNovo Nordisk NVO announced the surprise resignation of its chief executive officer (CEO), Lars Fruergaard Jørgensen. Sanofi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results